News Release

Limitations in Anti-cancer Drug Discovery

Volume 12

Book Announcement

Bentham Science Publishers

Frontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest advances in anti-cancer drug design and discovery. In each volume, eminent scientists contribute reviews relevant to all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series should prove to be of interest to all pharmaceutical scientists involved in research in anti-cancer drug design and discovery. The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.

This volume of the series focuses on reviews of treatments derived from natural sources (cannabinoid-based medicines and turmeric), immunotherapy, biomarkers for glioblastoma and some new drug targets for anti-cancer treatment.

The reviews in this 12th volume comprises of Cannabinoid-Based Anticancer Strategies and the Beneficial Effects of Turmeric and Its Active Constituent in Cancer Treatment. It also includes Immunotherapy Approaches Focusing on Cancer Stem Cellsand Immunotherapy for the Treatment of Hepatocellular Carcinoma. It portrays the Role of Biomarkers in Developing Therapies for Glioblastoma Multiforme and Poly (ADP-ribose) Polymerases as New Drug Targets in Cancer Treatment


About the Author:

Prof. Atta-ur-Rahman, Ph.D. in Organic Chemistry from Cambridge University (1968) has 1,232 international publications (45 international patents and 341 books). He received the following awards: Fellow Royal Society (FRS) London (2006), UNESCO Science Prize (1999), Honorary Life Fellow Kings College, Cambridge University (2007), Academician (Foreign Member) Chinese Academy of Sciences (2015), Highest Civil Award for Foreigners of China (Friendship Award, 2014), High Civil Award Austria (“Grosse Goldene Ehrenzeischen am Bande") (2007), Foreign Fellow Chinese Chemical Society (2013), Sc.D. Cambridge University (UK) (1987), TWAS (Italy) Prize (2009). He was the President of Network of Academies of Sciences of Islamic Countries (NASIC), Vice President TWAS (Italy), Foreign Fellow Korean Academy of Science & Technology, President Pakistan Academy of Sciences (2003-2006) and (2011 – 2014). He was the Federal Minister for Science and Technology of Pakistan (2000 – 2002), Federal Minister of Education (2002) and Chairman Higher Education Commission/Federal Minister (2002-2008), Coordinator General of COMSTECH (OIC Ministerial Committee) (1996-2012), and the Editor-in-Chief of Current Medicinal Chemistry.


Angeiogenesis, Cancer therapy, chemotherapy, lymphoblastic, leukemia, breast cancer, Nano medicines, Lung Cancer, Self-Nano emulsifying Drug Delivery System, Oral Cancer therapeutics, Drug Targeting in Cancer, Oncology, Chemotherapy.

For more Details Please visit :

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.